SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-19-026668
Filing Date
2019-12-20
Accepted
2019-12-20 15:30:52
Documents
59
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0919_inspyrtherapeutics.htm 10-Q 771395
2 CERTIFICATION f10q0919ex31-1_inspyr.htm EX-31.1 9712
3 CERTIFICATION f10q0919ex31-2_inspyr.htm EX-31.2 9711
4 CERTIFICATION f10q0919ex32-1_inspyr.htm EX-32.1 4648
5 CERTIFICATION f10q0919ex32-2_inspyr.htm EX-32.2 4878
  Complete submission text file 0001213900-19-026668.txt   3061325

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE nspx-20190930.xml EX-101.INS 401476
7 XBRL SCHEMA FILE nspx-20190930.xsd EX-101.SCH 39251
8 XBRL CALCULATION FILE nspx-20190930_cal.xml EX-101.CAL 36590
9 XBRL DEFINITION FILE nspx-20190930_def.xml EX-101.DEF 149026
10 XBRL LABEL FILE nspx-20190930_lab.xml EX-101.LAB 274375
11 XBRL PRESENTATION FILE nspx-20190930_pre.xml EX-101.PRE 213263
Mailing Address 2511 N LOOP 1604 W SUITE 204 SAN ANTONIO TX 78258
Business Address 2511 N LOOP 1604 W SUITE 204 SAN ANTONIO TX 78258 (210) 479-8112
Inspyr Therapeutics, Inc. (Filer) CIK: 0001421204 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55331 | Film No.: 191300941
SIC: 2834 Pharmaceutical Preparations